47 results
8-K
ALGS
Aligos Therapeutics Inc
7 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
(the “Staff”) of the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”), notifying the Company that, for the 30 consecutive business
S-1
EX-10.3
ALGS
Aligos Therapeutics Inc
25 Sep 20
IPO registration
5:27pm
disputes the amount of Additional Rent set forth in the Statement, a member of Tenant’s finance department, or an independent certified public accountant … Department Contractor or Subcontractor, and (ii) observe area standards for wages and other terms and conditions of employment, including fringe
8-K
EX-4.1
tw8x 92cg34zuu03egk
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-10.1
vdptffv zgz7ig
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
8-K
EX-4.2
nj9u8frgcvb8k zpf
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm
S-3
EX-1.2
pbjp82v2xzc5q0rfav
4 Nov 21
Shelf registration
4:57pm